Skip to search formSkip to main contentSkip to account menu

yttrium-90

Known as: Yttrium Y-90, yttrium Y 90, 90Y 
A radioactive form of the rare metal yttrium that is used in radiation therapy to treat some types of tumors. Yttrium Y 90 can be linked to a… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Yttrium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
The role of early 18F-FDG PET/CT in prediction of progression-free survival after 90Y radioembolization: comparison with RECIST and tumour density criteria
PurposeThis study evaluated the ability of 18F-FDG PET/CT imaging to predict early response to 90Y-radioembolization in… 
Highly Cited
2004
Highly Cited
2004
Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET.
UNLABELLED Our aim was to assess the feasibility of using PET for quantifying metabolic response after intraarterial (90)Y-glass… 
Highly Cited
1998
Highly Cited
1998
Pre‐clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor‐targeted scintigraphy and radionuclide therapy
We have evaluated the potential usefulness of radiolabelled [DTPA0,Tyr3]octreotide and [DOTA0,Tyr3]octreotide as… 
Highly Cited
1994
Highly Cited
1994
Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies.
UNLABELLED Serum stability and in vivo biodistribution of both A and B isomers of the 2-(p-isothiocyanatobenzyl) (p-SCN-Bz… 
Highly Cited
1994
Highly Cited
1994
Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres.
We calculated the mean absorbed fractions, specific absorbed fractions and mean doses per unit of cumulated activity in source… 
Highly Cited
1994
Highly Cited
1994
Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung.
UNLABELLED Yttrium-90 is a promising radionuclide for radioimmunotherapy of cancer because of its energetic beta emissions… 
Highly Cited
1990
Highly Cited
1990
Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent.
Yttrium-90 (90Y) is a promising radiometal for therapy of cancer due to its high-energy beta emission and a physical half-life of… 
Highly Cited
1990
Highly Cited
1990
Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer.
From March 1987 to March 1988, a phase I to II study was carried out in 25 patients with ovarian cancer. They received escalating… 
Highly Cited
1989
Highly Cited
1989
Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity.
One factor that is critical to the potential effectiveness of radioimmunotherapy is the design of radiometal-chelated antibodies… 
Highly Cited
1988
Highly Cited
1988
Patient biodistribution of intraperitoneally administered yttrium-90-labeled antibody.
Although 90Y is one of the best radionuclides for radioimmunotherapeutic applications, the lack of gamma rays in its decay… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)